Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coagulation factors are a group of proteins in the blood that play a crucial role in hemostasis, the process of stopping bleeding after vascular injury. These factors, mostly synthesized in the liver, activate in a cascade to ultimately convert fibrinogen to fibrin, forming a stable blood clot. Deficiencies or dysfunctions in these factors can lead to bleeding disorders, while dysregulation can contribute to thrombosis.
Various, including inhibition of specific coagulation factors (e.g., Warfarin inhibits Vitamin K-dependent factors), direct inhibition of thrombin or Factor Xa, or replacement of deficient factors.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coagulation Factors (Multiple) (N/A).